BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 22381622)

  • 21. Soluble guanylyl cyclase activator YC-1 inhibits human neutrophil functions through a cGMP-independent but cAMP-dependent pathway.
    Hwang TL; Hung HW; Kao SH; Teng CM; Wu CC; Cheng SJ
    Mol Pharmacol; 2003 Dec; 64(6):1419-27. PubMed ID: 14645672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement of long-term potentiation by a potent nitric oxide-guanylyl cyclase activator, 3-(5-hydroxymethyl-2-furyl)-1-benzyl-indazole.
    Chien WL; Liang KC; Teng CM; Kuo SC; Lee FY; Fu WM
    Mol Pharmacol; 2003 Jun; 63(6):1322-8. PubMed ID: 12761342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. YC-1 attenuates LPS-induced proinflammatory responses and activation of nuclear factor-kappaB in microglia.
    Lu DY; Tang CH; Liou HC; Teng CM; Jeng KC; Kuo SC; Lee FY; Fu WM
    Br J Pharmacol; 2007 Jun; 151(3):396-405. PubMed ID: 17401444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipoteichoic acid-induced nitric oxide synthase expression in RAW 264.7 macrophages is mediated by cyclooxygenase-2, prostaglandin E2, protein kinase A, p38 MAPK, and nuclear factor-kappaB pathways.
    Chang YC; Li PC; Chen BC; Chang MS; Wang JL; Chiu WT; Lin CH
    Cell Signal; 2006 Aug; 18(8):1235-43. PubMed ID: 16289764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the cyclic AMP-protein kinase A pathway in lipopolysaccharide-induced nitric oxide synthase expression in RAW 264.7 macrophages. Involvement of cyclooxygenase-2.
    Chen CC; Chiu KT; Sun YT; Chen WC
    J Biol Chem; 1999 Oct; 274(44):31559-64. PubMed ID: 10531359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of inducible nitric oxide synthase by cAMP-elevating phospho-diesterase inhibitors.
    Markovic M; Miljkovic Dj; Trajkovic V
    Curr Drug Targets Inflamm Allergy; 2003 Mar; 2(1):63-79. PubMed ID: 14561177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthetic strategy and structure-activity relationship (SAR) studies of 3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole (YC-1, Lificiguat): a review.
    Yu KH; Hung HY
    RSC Adv; 2021 Dec; 12(1):251-264. PubMed ID: 35424505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human alveolar macrophages and monocytes as a source and target for nitric oxide.
    Thomassen MJ; Kavuru MS
    Int Immunopharmacol; 2001 Aug; 1(8):1479-90. PubMed ID: 11515813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nitric oxide production by human macrophages: there's NO doubt about it.
    Fang FC; Vazquez-Torres A
    Am J Physiol Lung Cell Mol Physiol; 2002 May; 282(5):L941-3. PubMed ID: 11943657
    [No Abstract]   [Full Text] [Related]  

  • 30. Phagocytes and the lung.
    Ward PA
    Ann N Y Acad Sci; 1997 Dec; 832():304-10. PubMed ID: 9704058
    [No Abstract]   [Full Text] [Related]  

  • 31. YC-1 potentiates cAMP-induced CREB activation and nitric oxide production in alveolar macrophages.
    Hwang TL; Tang MC; Kuo LM; Chang WD; Chung PJ; Chang YW; Fang YC
    Toxicol Appl Pharmacol; 2012 Apr; 260(2):193-200. PubMed ID: 22381622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Nitric oxide. Potentiation of NO-dependent activation of soluble guanylate cyclase--(patho)physiological and pharmacotherapeutical significance].
    Severina IS
    Biomed Khim; 2007; 53(4):385-99. PubMed ID: 18035720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulating cGMP to treat lung diseases.
    Ghofrani HA; Grimminger F
    Handb Exp Pharmacol; 2009; 191(191):469-83. PubMed ID: 19089341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salutary properties of YC-1 in the cardiovascular and hematological systems.
    Tulis DA
    Curr Med Chem Cardiovasc Hematol Agents; 2004 Oct; 2(4):343-59. PubMed ID: 15320784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting NO/cGMP Signaling in the CNS for Neurodegeneration and Alzheimer's Disease.
    Ben Aissa M; Lee SH; Bennett BM; Thatcher GR
    Curr Med Chem; 2016; 23(24):2770-2788. PubMed ID: 27776476
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.